Comment
doi: 10.1038/nrn3530-c2. Epub 2013 Oct 23.New victims of current drug laws
Affiliations
- PMID:24149187
- DOI: 10.1038/nrn3530-c2
Item in Clipboard
Comment
New victims of current drug laws
David J Nutt et al. Nat Rev Neurosci.2013 Dec.
Display options
Format
Display options
Format
No abstract available
Comment on
- Effects of Schedule I drug laws on neuroscience research and treatment innovation.Nutt DJ, King LA, Nichols DE.Nutt DJ, et al.Nat Rev Neurosci. 2013 Aug;14(8):577-85. doi: 10.1038/nrn3530. Epub 2013 Jun 12.Nat Rev Neurosci. 2013.PMID:23756634
- Controlled substances and innovation of biomedicine: a preclinical perspective.Stewart AM, Kalueff AV.Stewart AM, et al.Nat Rev Neurosci. 2013 Dec;14(12):877. doi: 10.1038/nrn3530-c1. Epub 2013 Oct 23.Nat Rev Neurosci. 2013.PMID:24149185No abstract available.
Similar articles
- Controlled substances and innovation of biomedicine: a preclinical perspective.Stewart AM, Kalueff AV.Stewart AM, et al.Nat Rev Neurosci. 2013 Dec;14(12):877. doi: 10.1038/nrn3530-c1. Epub 2013 Oct 23.Nat Rev Neurosci. 2013.PMID:24149185No abstract available.
- Effects of Schedule I drug laws on neuroscience research and treatment innovation.Nutt DJ, King LA, Nichols DE.Nutt DJ, et al.Nat Rev Neurosci. 2013 Aug;14(8):577-85. doi: 10.1038/nrn3530. Epub 2013 Jun 12.Nat Rev Neurosci. 2013.PMID:23756634
- New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?Rychert M, Wilkins C.Rychert M, et al.Addiction. 2019 Jun;114(6):1129-1130. doi: 10.1111/add.14589. Epub 2019 Mar 20.Addiction. 2019.PMID:30801839No abstract available.
- Evolution of Italian laws banning trafficking, use and abuse of psychotropic drugs.Di Luca NM, Busardò FP, Pirani F, Varì MR.Di Luca NM, et al.Ann Ist Super Sanita. 2020 Jan-Mar;56(1):76-89. doi: 10.4415/ANN_20_01_12.Ann Ist Super Sanita. 2020.PMID:32242539Review.
- A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin GM, Nutt D.Zohar J, et al.Eur Neuropsychopharmacol. 2015 Dec;25(12):2318-25. doi: 10.1016/j.euroneuro.2015.08.019. Epub 2015 Sep 7.Eur Neuropsychopharmacol. 2015.PMID:26527055Review.
Cited by
- How Drug Control Policy and Practice Undermine Access to Controlled Medicines.Burke-Shyne N, Csete J, Wilson D, Fox E, Wolfe D, Rasanathan JJK.Burke-Shyne N, et al.Health Hum Rights. 2017 Jun;19(1):237-252.Health Hum Rights. 2017.PMID:28630556Free PMC article.
- Illegal drugs laws: clearing a 50-year-old obstacle to research.Nutt D.Nutt D.PLoS Biol. 2015 Jan 27;13(1):e1002047. doi: 10.1371/journal.pbio.1002047. eCollection 2015 Jan.PLoS Biol. 2015.PMID:25625189Free PMC article.
- Mind-altering drugs and research: from presumptive prejudice to a Neuroscientific Enlightenment?: Science & Society series on "Drugs and Science".Nutt D.Nutt D.EMBO Rep. 2014 Mar;15(3):208-11. doi: 10.1002/embr.201338282. Epub 2014 Feb 14.EMBO Rep. 2014.PMID:24531723Free PMC article.No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources